The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

Author(s): Hirokazu Tamamura, Hiroshi Tsutsumi, Nobutaka Fujii

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 6 , Issue 9 , 2006

Become EABM
Become Reviewer


CXCR4 is the receptor for a chemokine, CXCL12 (stromal cell-derived factor-1, SDF-1). The CXCL12- CXCR4 axis has been proven to be involved in several problematic diseases, including AIDS, cancer cell metastasis, leukemia cell progression and rheumatoid arthritis (RA). Thus, CXCR4 is thought to be an important therapeutic target to overcome the above diseases. We have developed several specific CXCR4 antagonists.

Keywords: Leukemia cell progression, cancer metastasis, chemokine receptor, HIV infection, low molecular weight CXCR4 antagonist, rheumatoid arthritis, T140, T22

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2006
Page: [989 - 995]
Pages: 7
DOI: 10.2174/138955706778195135
Price: $65

Article Metrics

PDF: 4